Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca PLC - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
New York
2830
www.astrazeneca.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca PLC
Amgen Just Gave Its Shareholders Great News
- Nov 2nd, 2026 10:45 am
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
- Nov 2nd, 2026 8:50 am
AstraZeneca results reassure on long-term growth as three brokers raise price targets
- Nov 2nd, 2026 7:00 am
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
- Nov 2nd, 2026 7:00 am
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
- Nov 2nd, 2026 5:00 am
SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus
- Nov 1st, 2026 11:11 pm
HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
- Nov 1st, 2026 5:00 pm
AstraZeneca: 3 Key Takeaways for Long-Term Investors
- Nov 1st, 2026 7:19 am
Haleon And 2 British AI Healthcare Stocks To Watch
- Nov 1st, 2026 3:13 am
AstraZeneca (AZN) Q3 2026 Earnings Call Transcript
- Oct 31st, 2026 9:58 am
Q3 earnings round-up: AstraZeneca, AbbVie, Kenvue
- Oct 30th, 2026 2:32 pm
AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion Potential
- Oct 30th, 2026 2:32 pm
COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?
- Oct 30th, 2026 1:46 pm
AstraZeneca Q3 Earnings Call Highlights
- Oct 30th, 2026 1:14 pm
Learn Why The Bull Case For AstraZeneca Stock Could Change Following Earnings Beat
- Oct 30th, 2026 12:12 pm
Scroll